Identification of Fibrosis-associated Biomarkers in Heart Failure and Human Cancers

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2024 Nov 20

PMID 39563337

Authors

Can Hou

Junyu Huo

Si Yan

Fei Sun

Xiaoyu Yang

Affiliations

Soon will be listed here.

Abstract

Background: Heart failure (HF) and cancer share common risk factors and pathophysiological mechanisms, including fibrosis. Identifying biomarkers and therapeutic targets for both conditions is crucial.

Materials And Methods: RNA sequencing data from HF patients were analyzed to identify 12 genes associated with myocardial fibrosis. Validation was performed using public datasets, and functional enrichment analyses were conducted. Gene expression patterns and prognostic value in various cancers were assessed.

Results: Fibromodulin (FMOD), Periostin (POSTN), Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2), Collagen Type I Alpha 1 Chain (COL1A1), Collagen Type VIII Alpha 1 Chain (COL8A1), Asporin (ASPN), and Hemoglobin Subunit Beta (HBB) showed significant dysregulation in heart failure tissues and were implicated in multiple cancer types. Pan-cancer analysis revealed associations between these genes and prognosis. Correlations with cancer-associated fibroblasts were also observed.

Conclusion: FMOD, POSTN, LTBP2, COL1A1, COL8A1, ASPN, and HBB are potential biomarkers for HF and cancer with fibrotic microenvironments. Targeting fibrosis may offer novel therapeutic approaches. Further validation and mechanistic studies are needed. This study contributes to understanding HF and cancer at the molecular level and suggests personalized treatment strategies.

References

Khamees I, Ata F, Choudry H, Soliman A, De Sanctis V, Yassin M . Manifestations of HbSE sickle cell disease: a systematic review. J Transl Med. 2021; 19(1):262. PMC: 8207785. DOI: 10.1186/s12967-021-02931-1. View

Xia L, Zhang T, Yao J, Lu K, Hu Z, Gu X . Fibromodulin overexpression drives oral squamous cell carcinoma via activating downstream EGFR signaling. iScience. 2023; 26(11):108201. PMC: 10641260. DOI: 10.1016/j.isci.2023.108201. View

Wang H, Huang R, Yang K, Xu M, Fan D, Liu M . Identification of differentially expressed genes and preliminary validations in cardiac pathological remodeling induced by transverse aortic constriction. Int J Mol Med. 2019; 44(4):1447-1461. PMC: 6713409. DOI: 10.3892/ijmm.2019.4291. View

Farkhondeh T, Llorens S, Pourbagher-Shahri A, Ashrafizadeh M, Talebi M, Shakibaei M . An Overview of the Role of Adipokines in Cardiometabolic Diseases. Molecules. 2020; 25(21). PMC: 7665135. DOI: 10.3390/molecules25215218. View

Xiang G, Huang L, Zhang X, Wang N, Wang H, Mu Y . Molecular Characteristics and Promoter Analysis of Porcine . Genes (Basel). 2022; 13(11). PMC: 9689670. DOI: 10.3390/genes13111971. View

Li H, Zhang Z, Chen L, Sun X, Zhao Y, Guo Q . Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer. Cell Death Dis. 2019; 10(2):109. PMC: 6365561. DOI: 10.1038/s41419-019-1376-9. View

Niu N, Miao H, Ren H . Effect of miR-182-5p on apoptosis in myocardial infarction. Heliyon. 2023; 9(11):e21524. PMC: 10685254. DOI: 10.1016/j.heliyon.2023.e21524. View

Wang J, Liang W, Min G, Wang H, Chen W, Yao N . LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer. Int J Oncol. 2018; 52(6):1886-1898. PMC: 5919710. DOI: 10.3892/ijo.2018.4356. View

Zhao F, Bai Y, Xiang X, Pang X . The role of fibromodulin in inflammatory responses and diseases associated with inflammation. Front Immunol. 2023; 14:1191787. PMC: 10360182. DOI: 10.3389/fimmu.2023.1191787. View

10.

Lin S, Liao Y, Chen P, Yang Y, Wang Y, Tung S . Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling. J Biomed Sci. 2022; 29(1):109. PMC: 9784270. DOI: 10.1186/s12929-022-00888-x. View

11.

Souza M, Colus I, Fonseca A, Antunes V, Kumar D, Cavalli L . MiR-182-5p Modulates Prostate Cancer Aggressive Phenotypes by Targeting EMT Associated Pathways. Biomolecules. 2022; 12(2). PMC: 8961520. DOI: 10.3390/biom12020187. View

12.

He W, Jin H, Liu Q, Sun Q . miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression. Mol Med Rep. 2020; 23(2). PMC: 7751459. DOI: 10.3892/mmr.2020.11769. View

13.

Meijers W, de Boer R . Common risk factors for heart failure and cancer. Cardiovasc Res. 2019; 115(5):844-853. PMC: 6452432. DOI: 10.1093/cvr/cvz035. View

14.

Sang Y, Chen B, Song X, Li Y, Liang Y, Han D . circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Mol Ther. 2019; 27(9):1638-1652. PMC: 6731174. DOI: 10.1016/j.ymthe.2019.05.011. View

15.

Li X, Jin Y . Inhibition of miR-182-5p attenuates ROS and protects against myocardial ischemia-reperfusion injury by targeting STK17A. Cell Cycle. 2022; 21(15):1639-1650. PMC: 9291646. DOI: 10.1080/15384101.2022.2060640. View

16.

Yan S, Wang H, Chen X, Liang C, Shang W, Wang L . MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Cancer Lett. 2020; 488:18-26. DOI: 10.1016/j.canlet.2020.04.021. View

17.

Landolt L, Spagnoli G, Hertig A, Brocheriou I, Marti H . Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches. Nephrol Dial Transplant. 2020; 37(6):1024-1032. DOI: 10.1093/ndt/gfaa301. View

18.

Travers J, Tharp C, Rubino M, McKinsey T . Therapeutic targets for cardiac fibrosis: from old school to next-gen. J Clin Invest. 2022; 132(5). PMC: 8884906. DOI: 10.1172/JCI148554. View

19.

Lin M, Chang Y, Wang S, Yang M, Chang C, Hsiao M . OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer. Antioxidants (Basel). 2021; 10(11). PMC: 8614815. DOI: 10.3390/antiox10111808. View

20.

Portokallidou K, Dovrolis N, Ragia G, Atzemian N, Kolios G, Manolopoulos V . Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy. Front Cardiovasc Med. 2023; 10:1115623. PMC: 9968758. DOI: 10.3389/fcvm.2023.1115623. View